Quality of myositis case reports open to improvement [2]

Arthritis Care and Research

Volumn 51, Issue 1, 2004, Pages 148-150

  Van De Vlekkert, Janneke ^a   Tjin A Ton, Manuel L R ^b   Hoogendijk, Jessica E ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DERMATOMYOSITIS; DRUG EFFICACY; DYNAMOMETRY; HUMAN; LETTER; MUSCLE BIOPSY; POLYMYOSITIS; RANDOMIZED CONTROLLED TRIAL;

DATABASES, FACTUAL; HUMANS; MEDICAL RECORDS; MYOSITIS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 1242314365     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
2. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
3. Barton S. Which clinical studies provide the best evidence? BMJ 2000;321:255-6.
4. Moher D, Schulz K, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
5. Huston P, Squires BP. Case reports: information for authors and peer reviewers. CMAJ 1996;154:43-4.
6. Jenicek M. Clinical case reporting in evidence-based medicine. 2nd ed. New York: Oxford University Press; 2001.